Previous studies of traffic-related pollution have observed associations between motor vehicle pollution and an array of adverse health outcomes, including respiratory and cardiovascular diseases ([@b46-ehp-117-373]). The immune system is a hypothesized biologic mediator of such health effects ([@b6-ehp-117-373]; [@b8-ehp-117-373]). The strongest evidence of an association between air pollution and immune status in adults comes from studies of serum levels of C-reactive protein (CRP)---an acute-phase reactant and well-established marker of inflammation---in which indicators of increased air pollution were associated with higher CRP levels ([@b7-ehp-117-373]; [@b9-ehp-117-373]; [@b10-ehp-117-373]; [@b33-ehp-117-373]; [@b34-ehp-117-373]; [@b35-ehp-117-373]; [@b37-ehp-117-373]; [@b39-ehp-117-373]; [@b48-ehp-117-373]; [@b49-ehp-117-373]). The hypothesis that air pollution may cause immune-suppressive effects is supported by animal studies demonstrating increased susceptibility to infection with diesel exhaust exposure \[[@b43-ehp-117-373]\] and epidemiologic studies showing increases in hospital admissions for respiratory infections with increases in nitrogen dioxide among the general population ([@b13-ehp-117-373]; [@b26-ehp-117-373]). None of the previous studies of air pollution and immune function in adults has directly evaluated exposure to traffic.

We studied the association between traffic-related pollution and biomarkers of systemic inflammation and cellular immunity in the Puget Sound region of Washington State. Because traffic-related pollutants, such as nitrogen dioxide and ultrafine particles, are high near major roadways and then decay exponentially over a short distance ([@b24-ehp-117-373]; [@b36-ehp-117-373]; [@b50-ehp-117-373]), we assessed exposure according to residential proximity to major roads. Our study population consisted of overweight, postmenopausal women, a group that may be particularly vulnerable to air pollution--related health effects, based on results of previous studies showing the strongest air pollution associations with inflammatory markers among obese persons ([@b10-ehp-117-373]; [@b49-ehp-117-373]).

We investigated three markers of systemic inflammation---CRP, serum amyloid A (SAA), and interleukin-6 (IL-6)---and two measures of cellular immunity, natural killer (NK) cell cytotoxicity and T-lymphocyte proliferation. CRP is a recognized predictor of cardiovascular disease, and SAA and IL-6 may also predict inflammation-related diseases ([@b11-ehp-117-373]; [@b21-ehp-117-373]; [@b23-ehp-117-373]; [@b47-ehp-117-373]). The NK cytotoxicity assay measures the ability of NK cells to kill cancerous target cells ([@b1-ehp-117-373]; [@b45-ehp-117-373]). Low levels of NK cytotoxicity are believed to reflect a defect in the natural immune response and may predict risk of future adverse health events, including infection and cancer ([@b18-ehp-117-373]; [@b25-ehp-117-373]; [@b28-ehp-117-373]; [@b31-ehp-117-373]). Higher levels of *in vitro* lymphocyte proliferation are believed to reflect a more effective immune response ([@b1-ehp-117-373]; [@b18-ehp-117-373]; [@b25-ehp-117-373]; [@b31-ehp-117-373]; [@b45-ehp-117-373]).

Materials and Methods
=====================

Study design
------------

We conducted a cross-sectional analysis of the associations between traffic-related pollution and a set of five immune assays using data from the baseline visit of an intervention trial of exercise conducted at the Fred Hutchinson Cancer Research Center (FHCRC) ([@b27-ehp-117-373]). In our study procedures, we complied with all applicable U.S. requirements (including the FHCRC and University of Washington institutional review boards), and all women gave written informed consent before participation in the study.

Study population
----------------

Women were recruited from the greater Seattle area from 1998 to 2000 to participate in the Physical Activity for Total Health study, a 12-month randomized controlled intervention trial comparing the effects of a moderate-intensity exercise intervention versus a stretching control program on endogenous sex hormones in postmenopausal women ([@b27-ehp-117-373]). Subjects in a substudy of immune function (*n* = 115) were women who also met criteria for measurement of immunologic outcomes. Women were 50--75 years of age, were nonsmokers, consumed fewer than two alcohol drinks per day, were sedentary, were overweight or obese \[body mass index (BMI) ≥ 25.0; or between 24.0 and 24.9 with percentage body fat \> 33%\], were postmenopausal and not taking hormone replacement therapy in the preceding 6 months, and had no history of invasive cancer, diabetes, cardiovascular disease, or asthma; additional eligibility criteria have been published previously ([@b27-ehp-117-373]). Women in the substudy of immune function were eligible if they had no current serious allergies, were not regular (two or more times/week) users of aspirin or other nonsteroidal anti-inflammatory medications, and were not using corticosteroids or other medications known to affect immune function ([@b41-ehp-117-373]).

Questionnaires and interviews
-----------------------------

Information on demographics (age, education, income, employment status, marital status, and race/ethnicity), smoking history, and exercise was collected via a self-administered questionnaire. Body height and weight were measured during a clinical exam using a standard protocol. Use of multivitamins was determined from an in-person interview with each subject where supplement labels were photocopied and data were abstracted.

Immune measures
---------------

All women came to the University of Washington Department of Laboratory Medicine for blood draws. Twelve-hour fasting blood samples were taken between 0730 and 0830 hours following strict blood-draw criteria described previously ([@b2-ehp-117-373]). Serum and plasma were processed within 1 hr of collection and stored at --70°C. All immune assays were conducted at the University of Washington Clinical Immunology Laboratory in the Department of Laboratory Medicine.

We measured serum CRP and SAA by latex-enhanced nephelometry using high- sensitivity assays on the Behring Nephelometer II analyzer (Dade-Behring Diagnostics, Deerfield, IL) with lower detection limits of 0.2 mg/L for CRP and 0.7 mg/L for SAA. The interassay (between-batch) coefficients of variation (CVs) were 5--9% for CRP and 4--8% for SAA.

For serum IL-6, we performed solid-phase sandwich enzyme-linked immunosorbent assays with the Biosource Human IL-6 Immunoassay kit (Biosource, Camarillo, CA). The interassay CVs were \< 10% for concentrations \> 35 pg/mL, and analytical sensitivity was 8 pg/mL.

Our method for measuring NK cytotoxicity using a flow-cytometric assay has been described previously ([@b41-ehp-117-373]). NK cells were isolated from peripheral blood mononuclear cells (PBMCs) obtained from 14 mL heparin-anticoagulated blood by Ficoll-Hypaque separation. We washed and diluted cells to a mononuclear cell concentration of 7.7 × 10^6^ cell/mL.

We prepared K562 target cells as follows: We washed cells in the log phase of growth twice and incubated them with label 3,3′-dioctadecyloxa carbocyanine perchlorate (DiO; Live/Dead cytotoxicity kit no. L7010; Molecular Probes, Eugene, OR). We incubated, washed, and resuspended the cells to a concentration of 1 × 10^6^ cells/mL and then filtered them through a 35-μm strainer.

We serially diluted the culture-suspended NK cells to four effector-to-target cell (E:T) ratios of 50:1, 25:1, 12.5:1, and 6.25:1 and then pelleted and incubated the cells. We added propidium iodide to a final concentration of 0.03 mg/mL and transferred the cells to a polypropylene tube for flow cytometric analysis to identify dead cells. We used the percentage of dead target cells among a total DiO-identified target cells as the measure of NK cytotoxicity. We performed each assay in duplicate and with appropriate controls. Within-run CVs ranged from 5.9% to 8.9%.

We assessed T-lymphocyte proliferation using cryopreserved PBMCs with two methods: ^3^H-thymidine incorporation in response to the mitogen phytohemagglutinin (PHA), and the cell-division tracking method in response to anti-CD3 antibody. We have described these assays previously ([@b2-ehp-117-373]). We prepared PBMCs by Ficoll-Hypaque separation and froze cells in 30% fetal calf serum, 60% RPMI medium, and 10% dimethyl sulfoxide (Gibco, Gaithersburg, MD). We included cells from two control subjects in every run.

For the ^3^H-thymidine incorporation, we incubated PBMCs in microtiter plates with PHA of 0.1 and 0.5 μg/mL in five replicates each. After incubation for 3 days at 37°C, we pulsed the cells for 24 hr with ^3^H-thymidine and then harvested and counted the cells with a β-counter. We express the PHA-stimulated lymphocyte proliferation index as counts per minute of stimulated cells divided by counts per minute of unstimulated cells.

For the cell-division tracking method, we added carboxy-fluorescein diacetate succin-imidyl ester (Molecular Probes), a precursor of carboxy-fluorescein succinimidyl ester suspension at a final concentration of 10 μM. We incubated, washed twice, and resuspended the cells and then pipetted them into 16 wells of a microtiter plate (100,000 cells/well). Next, we added anti-CD3 antibody (BD Biosciences, San Jose, CA) to eight of the wells to specifically stimulate T lymphocytes. We used the remaining eight wells as control unstimulated cells. After incubation for 3 days at 37°C, we pooled identical wells and incubated the cells for 3 more days. On the sixth day, we harvested the cells and measured the CFSE--fluorescein isothiocyanate intensity of viable lymphocytes with a flow cytometer (XL-MCL; Beckman Coulter, Miami, FL).

We report four variables that quantify anti-CD3--stimulated lymphocyte proliferation measured by the cell-division tracking method: *a*) The proliferation index is the ratio of the total number of cells (parent and newly proliferated) to the number of back-calculated original parent cells; *b*) the parent percent represents the percentage of cells in the source cell population that did not divide; *c*) the precursor frequency represents the fraction of cells from the source population (i.e., parent cells) that divided three or more times; and *d*) the upper generational proliferation index is the ratio of the total number of cells (parent and newly proliferated from generations three and above) to the number of back-calculated original parent cells ([@b2-ehp-117-373]).

Geocoding
---------

We geocoded subjects' residences at the study baseline using ArcGIS software (version 9.0) and StreetMapUSA data (2004; both software and data from Environmental Systems Research Institute, Redlands, CA).

Traffic proxy measures
----------------------

We obtained 2005 data on road networks through the Washington State Geospatial Data Archive ([@b44-ehp-117-373]). Freeways are defined as limited-access highways ([@b16-ehp-117-373]). Arterials are major roads between communities, population centers, and facilities. Truck routes are state routes or arterials designated by the city of Seattle as accommodating "significant freight movement" ([@b40-ehp-117-373]); these data were available only for the city of Seattle. Freeway, arterial, and truck route road networks are shown in [Figure 1](#f1-ehp-117-373){ref-type="fig"}.

We measured the distance from the subject's residence to the nearest road of each particular type using ArcGIS. We computed several traffic proxy variables for each road type. A dichotomous variable indicated the presence of a particular type of road within 150 m of the subject's residence. We chose the distance of 150 m for the "at-risk" category *a priori* based on findings from previous research that suggest that pollutants generated from on-road vehicles drop off exponentially with distance from the edge of a road, and that these vehicle-generated pollutants compose only a small fraction of the total pollutants at \> 150 m ([@b50-ehp-117-373]). However, we experimented with cut points of 100 and 200 m for the "at-risk" distance to evaluate the sensitivity of our results to the cut point chosen. We also created a set of indicator variables for categories of increasing residential proximity to the nearest road of each particular type (categories of \> 300--500 m, \> 200--300 m, \> 150--200 m, \> 100--150 m, \> 50--100 m, and 0--50 m, with \> 500 m as the referent).

Census covariates
-----------------

We extracted census tract variables from the 2000 Census Summary File 3 ([@b42-ehp-117-373]), including variables describing the racial and ethnic composition, unemployment rate, median income, education level, housing tenure rate, and population and housing density of the residential census tract for each subject.

Statistical analysis
--------------------

We performed all statistical analysis using SAS version 9.0 (SAS Institute Inc., Cary, NC). Because of skewed distributions, we transformed CRP and SAA data using the natural logarithm, and IL-6 using the natural logarithm of the observed value plus 0.5.

We used linear regression analysis to investigate associations between each of the traffic proxy metrics and each of the immune outcomes, adjusting for potential confounding factors. We considered CRP, SAA, IL-6, and T-lymphocyte proliferation stimulated by PHA or anti-CD3 as independent outcomes. We considered NK cytotoxicity as a nonindependent repeated measure in generalized estimating equations (GEEs) using the two intermediate E:T ratio dilutions: 12.5:1 and 25:1; these two dilutions had the greatest reproducibility and were in the linear range ([@b41-ehp-117-373]). For the dichotomous traffic proxy variables for residence within 150 m of a particular road type, we present model-adjusted least squares means and 95% confidence intervals (CIs) for each category, generated from the lsmeans statement of Proc GENMOD in SAS.

We selected variables *a priori* for adjustment as potential confounders, including age, BMI, education (individual-level), season of enrollment, time spent outdoors, and median income in the census tract of residence. We investigated associations of the traffic proxies with the immune outcomes among several pairs or trios of subgroup strata: *a*) overweight (BMI \< 30) versus obese (BMI ≥ 30) subjects; *b*) low (\< \$35,000) versus middle (\$35,000 to \$75,000) versus high (\> \$75,000) income; and *c*) subjects reporting an hour or more of exercise near traffic versus subjects reporting no exercise near traffic in the previous 3 months on the baseline questionnaire.

Results
=======

Study population
----------------

The 115 women in the study were highly educated, mostly non-Hispanic white, with high BMI; almost half the study population was classified as obese (BMI ≥ 30 kg/m^2^) ([Table 1](#t1-ehp-117-373){ref-type="table"}); 27% (*n* = 31) of women in the study lived near (within 150 m) major arterials, 3% (*n* = 3) lived near freeways, and 15% (*n* = 9) of the 61 residents of Seattle, where truck routes were assessed, lived near designated truck routes. Women who lived near arterials were more likely to be younger, nonwhite, and less educated than those who did not and were more likely to live in census tracts in which the median income was lower; however, only the difference in census tract--level income was statistically significant ([Table 1](#t1-ehp-117-373){ref-type="table"}). Women who lived near arterials reported similar amounts of time spent outdoors compared with women who did not live near arterials. [Table 2](#t2-ehp-117-373){ref-type="table"} shows the distribution of each immune outcome and the number of subjects with data for inclusion in analyses. We did not have adequate power to assess the effect of living near freeways, because only three subjects lived within 150 m of a freeway (data not shown).

We observed a statistically significant association, in our hypothesized direction of effect, between residence near arterials and NK cytotoxicity, within our *a priori* hypothesized at-risk group of women living within 150 m of major roads ([Table 3](#t3-ehp-117-373){ref-type="table"}). Those who lived near arterials had, on average, NK cyto toxicity (expressed as the percentage of cells killed) of 19.5% (95% CI, 15.6--23.4%), compared with 24.8% (95% CI, 22.0--27.5%) among those who did not live near arterials. NK cytotoxicity was also lower among those living near truck routes than among those who did not, although this was not significant at a two-sided α level of 0.05. These associations were not sensitive to our *a priori* choice of covariates for adjustment of potential confounding; for example, models without inclusion of the covariates generated similar estimates for the mean NK cytotoxicity among those living near arterials (19.3%; 95% CI, 15.5--23.0%) and those living farther away (24.8%; 95% CI, 22.1--27.6%). The association between NK cytotoxicity and living near arterials was limited to those women who reported exercising near traffic ([Table 4](#t4-ehp-117-373){ref-type="table"}) or among women in the middle group of individual income (\$35,000 to \$75,000) (data not shown).

We observed significant associations of NK cytotoxicity with living near arterials when using alternate cut points of either 100 or 200 m for our definition of proximity to traffic, and the magnitudes of the associations were similar to our main analysis, indicating that this result was not excessively sensitive to our *a priori* cut point of 150 m. Residential proximity to truck routes was not significantly associated with NK cytotoxicity in the analysis using 100 m as the alternate cut point, and the association was strongest when using the cut point of 200 m. Estimated NK cytotoxicity was 15.5% among women living within 200 m of truck routes compared with 26.2% among women living at greater distances, and this difference was highly significant (*p* = 0.0009; data not shown).

There were no trends of association with increasing proximity to major roads for either road type, in models including indicator variables for categories of distance from a major road compared with a reference category of \> 500 m \[Supplemental Material, Table 1 (<http://www.ehponline.org/members/2008/11580/suppl.pdf>)\].

We observed no associations between the markers of inflammation (CRP, SAA, IL-6) or PHA-stimulated lymphocyte proliferation and the traffic proxy variables ([Table 5](#t5-ehp-117-373){ref-type="table"}). We noted a significantly lower average upper generational proliferation index---one of the four measures of anti-CD3--stimulated lymphocyte proliferation---associated with residence near major arterials ([Table 5](#t5-ehp-117-373){ref-type="table"}). The other three measures of anti-CD3--stimulated lymphocyte proliferation were not associated with residence near arterials ([Table 5](#t5-ehp-117-373){ref-type="table"}), nor was residence near truck routes associated with any of the anti-CD3--stimulated lymphocyte proliferation measures (data not shown).

Discussion
==========

Ours is the first study, to our knowledge, of the association of traffic proxy measures and functional assays of cellular immunity. We observed an internally consistent association between residence within 150 m of major arterials or truck routes and lower NK cytotoxicity. The association was limited to those who reported exercising outdoors near traffic---individuals who presumably had higher exposure to traffic-related pollutants. We also found an association of living near arterials with lower than average lymphocyte proliferation; however, this result was not internally consistent among the various traffic proxy variables or lymphocyte proliferation measures, and we therefore consider the association tenuous. We observed no association between the traffic proxies and inflammation markers. In our modest-sized study, we analyzed five assays of immune status and several traffic proxy variables; therefore, our statistically significant results should be cautiously interpreted with respect to the possibility of chance findings and according to the consistency and robustness of the results.

NK cells are involved in the innate immune response and can destroy virally infected and transformed cells ([@b19-ehp-117-373]). Although the relationship between *in vivo* NK function and NK cytotoxicity is unclear, low NK cytotoxicity has been associated with increased risk of infection, increased cancer risk, and increased risk of death among cancer survivors and institutionalized elderly ([@b1-ehp-117-373]; [@b18-ehp-117-373]; [@b22-ehp-117-373]; [@b25-ehp-117-373]; [@b31-ehp-117-373]). Researchers have found some evidence of associations between air pollution from traffic and infections ([@b5-ehp-117-373], [@b3-ehp-117-373], [@b4-ehp-117-373]; [@b13-ehp-117-373]; [@b26-ehp-117-373]; [@b30-ehp-117-373]; [@b43-ehp-117-373]), and associations between air pollution and NK cytotoxicity would strengthen the evidence for this important clinical outcome by suggesting a potential underlying biologic mechanism. The studies relating measures of ambient or traffic-related air pollution to colds and other infections have been conducted mostly among young children, and further research among older adults is needed to understand the possible health implications of the association we observed between reduced NK cytotoxicity and proximity to traffic.

In contrast to our results for NK cytotoxicity, we observed no consistent associations between traffic proxies and lymphocyte proliferation measures. As a predictor, lower *in vitro* lymphocyte proliferation has been found to be correlated with worse HIV prognosis ([@b17-ehp-117-373]; [@b38-ehp-117-373]), and we would expect that a human whose lymphocytes experience a decreased ability to proliferate upon stimulation would have increased vulnerability to infection. Nevertheless, it is not known whether an increased proliferative response in the *in vitro* lymphocyte proliferation assay corresponds with a more effective physiologic immune response ([@b45-ehp-117-373]). Measures from lymphocyte proliferation assays have proven to be less sensitive than NK cytotoxicity assays in nutrition intervention studies, indicating potentially lower sensitivity of lymphocyte proliferation to detect *in vivo* effects from external exposures ([@b1-ehp-117-373]).

On the basis of previous studies, we hypothesized an association between proximity to traffic and increased levels of CRP. About half of the previous studies of air pollution and CRP have observed associations between CRP and at least one measure of air pollution (usually a specific pollutant, e.g., fine or coarse PM) ([@b7-ehp-117-373]; [@b9-ehp-117-373]; [@b10-ehp-117-373]; [@b33-ehp-117-373]; [@b34-ehp-117-373]; [@b35-ehp-117-373]; [@b37-ehp-117-373]; [@b39-ehp-117-373]; [@b48-ehp-117-373]; [@b49-ehp-117-373]); the prior evidence for associations of specific air pollutants with other inflammation markers, such as SAA or IL-6, is limited and conflicting ([@b7-ehp-117-373]; [@b9-ehp-117-373]; [@b12-ehp-117-373]; [@b14-ehp-117-373]; [@b15-ehp-117-373]; [@b39-ehp-117-373]). There are several differences between our exposure metric and the studies that found an association with CRP. In the previous studies, higher CRP levels were associated with air pollution levels during a very recent time period such as the same day or preceding 1--9 days. Our exposure metric reflects an average exposure to local traffic-related pollutants in which short-term fluctuations due to background urban air pollution or personal exposures are not captured. It is possible that CRP levels (and other inflammatory markers) change in response to recent exposures in the preceding days or weeks, in which case our metric of average exposure would not be appropriate for modeling the association. Second, proximity to major roads represents the potential for mixed pollutant exposure from traffic. If the inflammatory response is specific to a certain pollutant such as PM, then the nonspecificity of our exposure metric may have obscured any association.

The strengths of this study include the objective outcome assessment using bio-markers, the strict criteria for blood draws, use of state-of-the-art assays for characterizing immune function, objective exposure assessment using a geographic information system (GIS), and the homogeneity of the study population. Our study also had several limitations. Although assigning exposure based on proximity to major roads is a straightforward approach to evaluating exposure to a pollution source, it is not as sophisticated as other approaches such as dispersion modeling. Measurement campaigns have indicated that although proximity measures are correlated with traffic pollutants, mis-classification occurs due to varying terrain and meteorologic conditions ([@b20-ehp-117-373]); therefore, our traffic proxies are subject to misclassification that may have caused spurious results. The proximity metric we employed may also be more vulnerable to confounding by socioeconomic factors or traffic-related noise than would more specific air pollutant exposure models. Nevertheless, adjustment for multiple individual-level and census tract--level socioeconomic variables did not change the associations we observed.

In this article, we report an association between residential proximity to traffic and an important *in vitro* marker of cellular immunity. Our study population was selected to be overweight or obese, but otherwise healthy. Approximately two-thirds of U.S. women in the age group we studied fall into this category ([@b29-ehp-117-373]; [@b32-ehp-117-373]), and if the associations we observed are true, they would be relevant for a large proportion of the population. Additional studies of clinically relevant immune events such as infections and colds in relation to traffic-related pollution are needed to clarify the impact of traffic on the immune system and inform local land use policy.

C[orrection]{.smallcaps}
========================

The values for the two rows "Proliferation index---PHA" in [Table 5](#t5-ehp-117-373){ref-type="table"} were incorrect in the manuscript originally published online. They have been corrected here.

Supplemental Material is available online at <http://www.ehponline.org/members/2008/11580/suppl.pdf>
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###### 

Study population characteristics.

  Characteristic                                                               All subjects (*n* = 115)   Not near arterial[a](#tfn1-ehp-117-373){ref-type="table-fn"} (*n* = 84)   Near arterial[a](#tfn1-ehp-117-373){ref-type="table-fn"} (*n* = 31)   *p*-Value[b](#tfn2-ehp-117-373){ref-type="table-fn"}
  ---------------------------------------------------------------------------- -------------------------- ------------------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------
  Age, years \[no. (%)\]                                                                                                                                                                                                                                  
   50--55                                                                      33 (29)                    23 (27)                                                                   10 (32)                                                               0.38
   56--60                                                                      33 (29)                    24 (29)                                                                   9 (29)                                                                
   61--65                                                                      16 (14)                    13 (15)                                                                   3 (10)                                                                
   66--70                                                                      16 (14)                    14 (17)                                                                   2 (6)                                                                 
   71--75                                                                      17 (15)                    10 (12)                                                                   7 (23)                                                                
   Mean ± SD                                                                   60.7 ± 6.8                 60.6 ± 6.7                                                                61.1 ± 7.3                                                            0.55
  BMI \[no. (%)\]                                                                                                                                                                                                                                         
   24 to \< 30                                                                 63 (55)                    46 (55)                                                                   17 (55)                                                               0.99
   30 to \< 35                                                                 37 (32)                    27 (32)                                                                   10 (32)                                                               
   ≥ 35                                                                        15 (13)                    11 (13)                                                                   4 (13)                                                                
   Mean ± SD                                                                   30.3 ± 3.9                 30.3 ± 3.9                                                                30.2 ± 3.9                                                            0.95
  Race \[no. (%)\][c](#tfn3-ehp-117-373){ref-type="table-fn"}                                                                                                                                                                                             
   White (not of Hispanic origin)                                              101 (89)                   75 (90)                                                                   26 (84)                                                               0.33
   Nonwhite                                                                    13 (11)                    8 (10)                                                                    5 (16)                                                                
  Education \[no. (%)\]                                                                                                                                                                                                                                   
   High school or less                                                         17 (15)                    13 (15)                                                                   4 (13)                                                                0.54
   Some college or college degree                                              57 (50)                    39 (46)                                                                   18 (58)                                                               
   Graduate degree                                                             41 (36)                    32 (38)                                                                   9 (29)                                                                
  Season of enrollment \[no. (%)\]                                                                                                                                                                                                                        
   Winter                                                                      23 (20)                    18 (21)                                                                   6 (19)                                                                0.96
   Spring                                                                      44 (38)                    31 (37)                                                                   12 (39)                                                               
   Summer                                                                      23 (20)                    16 (19)                                                                   7 (23)                                                                
   Fall                                                                        25 (22)                    19 (23)                                                                   6 (19)                                                                
  Time spent outdoors \[no. (%)\][c](#tfn3-ehp-117-373){ref-type="table-fn"}                                                                                                                                                                              
   0--1 hr/week                                                                17 (15)                    13 (15)                                                                   4 (13)                                                                0.97
   2 hr/week                                                                   24 (21)                    18 (21)                                                                   6 (19)                                                                
   3--5 hr/week                                                                29 (25)                    21 (25)                                                                   8 (26)                                                                
   6 or more hr/week                                                           45 (39)                    32 (38)                                                                   13 (42)                                                               
  Median income of the census tract of residence (mean ± SD × 1,000)           \$58 ± \$18                \$62 ± \$19                                                               \$50 ± \$14                                                           0.04

"Near arterial": an arterial road was located within 150 m of a woman's residence.

For continuous variables, the *p*-value is from a *t*test (assuming equal variances) comparing the variable values between those living near arterials and those not-living near arterials; for categorical variables, the *p*-value is from a Pearson chi-square test of independence.

Numbers not equal to total because of missing data.

###### 

Immune biomarker distributions in the study population.

  Biomarker                                                                          No.[a](#tfn4-ehp-117-373){ref-type="table-fn"}   Mean ± SD      Minimum   Maximum
  ---------------------------------------------------------------------------------- ------------------------------------------------ -------------- --------- ---------
  Inflammation markers                                                                                                                                         
   CRP (mg/L)                                                                        114                                              3.7 ± 3.5      0.2       23.3
   SAA (mg/L)                                                                        114                                              6.2 ± 5.5      1.4       43.0
   IL-6 (pg/mL)                                                                      115                                              3.3 ± 3.1      0         20.0
  NK cytotoxicity (%)                                                                                                                                          
   25:1 E:T ratio                                                                    114                                              26.9 ± 13.3    4.35      68.9
   12.5:1 E:T ratio                                                                  114                                              19.8 ± 12.0    3.15      59.6
  PHA-stimulated lymphocyte proliferation                                                                                                                      
   Proliferation index[b](#tfn5-ehp-117-373){ref-type="table-fn"}---PHA 0.1 μg/Ml    110                                              76.8 ± 47.5    2.1       209.5
   Proliferation index[b](#tfn5-ehp-117-373){ref-type="table-fn"}---PHA 0.5 μg/mL    110                                              207.3 ± 95.9   2.4       457.4
  Anti-CD3--stimulated lymphocyte proliferation                                                                                                                
   Proliferation index[c](#tfn6-ehp-117-373){ref-type="table-fn"}                    93                                               4.9 ± 2.0      1.3       11.8
   Precursor frequency[d](#tfn7-ehp-117-373){ref-type="table-fn"}                    93                                               0.3 ± 0.1      0.02      0.5
   Parent percent (%)[e](#tfn8-ehp-117-373){ref-type="table-fn"}                     93                                               15.0 ± 11.7    4.4       71.9
   Upper generation proliferation index[f](#tfn9-ehp-117-373){ref-type="table-fn"}   93                                               15.3 ± 5.2     7.3       31.7

The number of women with nonmissing data for each assay is shown.

Counts per minute of stimulated cells/counts per minute of unstimulated cells.

Total number of cells (parent and newly proliferated) divided by the number of back-calculated original parent cells

Fraction of cells from the source population (i.e., parent cells) that divided three or more times.

Percentage of cells in the source cell population that did not divide.

Total number of cells (parent and newly proliferated from generations three and above) divided by the number of back-calculated original parent cells.

###### 

NK cytotoxicity by residence near (within 150 m) different major road types.

  Residence                                                                No.   NK cytotoxicity (%) \[mean (95% CI)\]
  ------------------------------------------------------------------------ ----- ---------------------------------------
  Residence near arterial                                                        
   No                                                                      84    24.8 (22.0--27.5)
   Yes                                                                     30    19.5 (15.6--23.4)
   Difference between means                                                      *p* = 0.047
  Residence near truck route[a](#tfn11-ehp-117-373){ref-type="table-fn"}         
   No                                                                      51    25.5 (22.1--28.9)
   Yes                                                                     9     17.0 (10.9--23.1)
   Difference between means                                                      *p* = 0.06

For each major road type, we present model-adjusted least squares means of NK cytotoxicity at 12.5:1 and 25:1 E:T ratios generated from the lsmeans statement in proc GENMOD using a generalized estimating equation regression, while accounting for within-person correlation. The *p*-values represent an analysis of variance test of the difference between means. Estimates are adjusted for covariates selected *a priori*: age, BMI, education, blood draw season, time spent outdoors, and median income of residential census tract.

Truck routes were classified only for the City of Seattle, where 61 women lived, and 60 of these women had non-missing data for NK cytotoxicity.

###### 

NK cytotoxicity by residence near (within 150 m) different major road types and exercise near traffic.

                                                                 NK cytotoxicity (%)                                                    
  -------------------------------------------------------------- --------------------- ------------ -------------- ------------- ------ --------------
  Near arterial[a](#tfn13-ehp-117-373){ref-type="table-fn"}                                                                             
   No                                                            51                    21.4         (18.6--24.1)   26            28.8   (23.8--33.8)
   Yes                                                           11                    21.0         (13.6--28.5)   15            20.7   (14.8--26.4)
   Difference between means                                                            *p* = 0.93                  *p* = 0.08           
  Near truck route[a](#tfn13-ehp-117-373){ref-type="table-fn"}                                                                          
   No                                                            23                    21.1         (17.7--24.4)   22            29.7   (26.0--33.4)
   Yes                                                           3                     24.6         (13.1--36.1)   6             10.2   (2.9--17.5)
   Difference between means                                                            *p* = 0.58                  *p* \< 0.01          

For each major road type, we present model-adjusted least squares means of NK cytotoxicity at 12.5:1 and 25:1 E:T ratios generated from the lsmeans statement in proc GENMOD using a generalized estimating equation regression, while accounting for within-person correlation. The *p*values represent an analysis of variance test of the difference between-means. Estimates are adjusted for covariates selected *a priori*: age, BMI, education, blood draw season, time spent outdoors, and median income of residential census tract.

Nonmissing data on both NK cytotoxicity and exercise near traffic were available for 103 women in the study area, and for 54 women in the City of Seattle where truck routes were assessed.

###### 

Inflammation and lymphocyte proliferation measures by residence near (within 150 m) arterial road (estimated mean and 95% CIs).

  Measure                                                                             Near arterial          Difference between means   
  ----------------------------------------------------------------------------------- ---------------------- -------------------------- ------------
  Inflammation markers                                                                *n* = 83               *n* = 31                   
   CRP (mg/mL)                                                                        2.5 (2.1--3.0)         2.3 (1.6--3.1)             *p* = 0.62
   IL-6 (pg/mL)[b](#tfn16-ehp-117-373){ref-type="table-fn"}                           2.4 (2.0--2.9)         2.1 (1.5--2.9)             *p* = 0.51
   SAA (mg/mL)                                                                        4.9 (4.3--5.5)         5.3 (4.3--6.6)             *p* = 0.52
  PHA-stimulated lymphocyte proliferation                                             *n* = 80               *n* = 30                   
   Proliferation index[c](#tfn17-ehp-117-373){ref-type="table-fn"}---PHA 0.1 μg/mL    75.2 (64.7--85.8)      81.2 (63.6--98.7)          *p* = 0.57
   Proliferation index[c](#tfn17-ehp-117-373){ref-type="table-fn"}---PHA 0.5 μg/mL    206.9 (185.0--228.8)   208.4 (172.0--244.9)       *p* = 0.94
  Anti-CD3--stimulated lymphocyte proliferation                                       *n* = 66               *n* = 27                   
   Proliferation index[d](#tfn18-ehp-117-373){ref-type="table-fn"}                    4.9 (4.4--5.4)         4.7 (4.0--5.5)             *p* = 0.68
   Parent percent[e](#tfn19-ehp-117-373){ref-type="table-fn"}                         17.3 (14.3--20.3)      16.2 (11.5--21.0)          *p* = 0.71
   Precursor frequency[f](#tfn20-ehp-117-373){ref-type="table-fn"}                    0.26 (0.23--0.28)      0.28 (0.24--0.32)          *p* = 0.32
   Upper generation proliferation index[g](#tfn21-ehp-117-373){ref-type="table-fn"}   16.0 (14.8--17.2)      13.5 (11.7--15.5)          *p* = 0.04

For each major road type, we present model-adjusted least squares means of each immune measure generated fom the lsmeans statement in proc GENMOD. The *p*-values represent an analysis of variance test of the difference between means. Estimates are adjusted for covariates selected *a priori*: age, BMI, education, blood draw season, time spent outdoors, and median income of residential census tract.

Numbers reflect the distribution of the complete study population of 115 women; the number of women with nonmissing data for each assay varies, as shown.

There were no missing data for the IL-6 assay; *n* = 115.

Counts per minute of stimulated cells/counts per minute of unstimulated cells.

Total number of cells (parent and newly proliferated) divided by the number of back-calculated original parent cells.

Percentage of cells in the source cell population that did not divide.

Fraction of cells from the source population (i.e., parent cells) that divided three or more times.

Total number of cells (parent and newly proliferated from generations three and above) divided by the number of back-calculated original parent cells.
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